56 new cases in Hunan



During the 24 hours of January 29, 56 new confirmed cases of pneumonia caused by the novel coronavirus (2019-nCoV) in Hunan. No people died of the disease and no patients were discharged from hospitals.


, 11 35110341333531




A total of 4434 close contacts have been traced, among whom 4297 are under medical observation while 137 others have been discharged.


About coronavirus symptomsses?


Symptoms of the new coronavirus are similar to pneumonia, and can range from mild symptoms, like a slight cough, to more severe symptoms, including fever and difficulty breathing.

Here's what you need to know about the newcoronavirus.

General disinfection guidelines


News More>>
Good News

[China Daily] 


Chinese researchers have found three existing drugs with fairly good inhibitory effects on the novel coronavirus (2019-nCoV) at the cellular level, a local newspaper has reported.

The three drugs are Remdesivir, Chloroquine and Ritonavir. They are now under relevant procedures to gain approval for clinical use, said Hubei Daily on Wednesday.

The discovery was jointly made by researchers from the Academy of Military Medical Sciences and the Wuhan Institute of Virology (WIV) under the Chinese Academy of Sciences (CAS).

28;(2019-nCoV)(RemdesivirGS-5734)(Chloroquine, Sigma-C6628)(Ritonavir)

Three Foreigners Infected

[China Daily] 

a Pakistani and two Australians have been diagnosed with the novel coronavirus in Guangdong province. All of whom have been hospitalized and are in stable condition.

The Pakistani was studying at a university in Wuhan, Hubei province before traveling to Shenzhen in Guangdong on Jan 21 and Guangzhou in Guangdong on Jan 24, and fell ill on Jan 26, deputy director of provincial health commission Chen Zhusheng said at a press conference on Wednesday.

Two Australians were traveling in Wuhan before coming to Guangdong and falling ill, Chen said. They are being treated in Shenzhen. 



China DailyShineXinhuanetHOCOS


Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments